Last reviewed · How we verify
Heparin Low Dose
Heparin Low Dose is a Small molecule drug developed by University Hospital, Bordeaux. It is currently FDA-approved.
Heparin Low Dose is used to treat conditions such as Pulmonary Thromboembolisms, Pulmonary Embolism, Anemia, Sickle Cell, and Acute Chest Syndrome. It works as an Antithrombin-III activator, a type of oligosaccharide that belongs to the ACTIVATOR drug class.
At a glance
| Generic name | Heparin Low Dose |
|---|---|
| Sponsor | University Hospital, Bordeaux |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility
- Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
- Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage (NA)
- The Intensive Care Platform Trial (PHASE4)
- Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis (PHASE3)
- Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management (NA)
- Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial (NA)
- A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Heparin Low Dose CI brief — competitive landscape report
- Heparin Low Dose updates RSS · CI watch RSS
- University Hospital, Bordeaux portfolio CI
Frequently asked questions about Heparin Low Dose
What is Heparin Low Dose?
Who makes Heparin Low Dose?
What development phase is Heparin Low Dose in?
Related
- Manufacturer: University Hospital, Bordeaux — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing